Ovulation is the single most essential event in every conception cycle. When it happens reliably and on schedule, it is invisible simply the biology working as intended. When it fails, the consequences are immediate and measurable: irregular or absent periods, difficulty conceiving despite regular intercourse, and month after month of uncertainty. Ovulation disorders account for approximately 30 percent of female infertility cases, making them the most common diagnosable cause of difficulty conceiving. For women in Kolkata, across Bangladesh, and throughout South Asia where PCOS prevalence is significantly elevated above the global average, ovulation disorder treatment is not a niche subspecialty concern it is the central fertility issue for a large proportion of couples seeking care. Nova IVF Fertility Centre, Kolkata brings a specialist fertility team, evidence-based ovulation induction protocols, and the full range of advanced reproductive technology to ovulation disorders treatment in Kolkata addressing the full spectrum from medication-responsive anovulation through to IVF for cases where simpler interventions have not produced conception.
Understanding Ovulation Disorders: What They Are and Why They Matter
An ovulation disorder is any condition that prevents the regular release of a mature egg from the ovary at the appropriate point in the menstrual cycle. The World Health Organisation classifies ovulation disorders into three groups based on the hormonal mechanism underlying the problem.
WHO Classification of Ovulation Disorders
WHO Group I Hypogonadotropic Hypogonadal Anovulation: Low FSH, low LH, and low oestrogen, resulting from hypothalamic or pituitary failure to signal the ovaries. This group includes hypothalamic amenorrhoea from extreme weight loss, excessive exercise, or psychological stress, as well as Kallmann syndrome and hypopituitarism. The ovaries are normal but not receiving the hormonal signal to develop follicles.
WHO Group II Normogonadotropic Normoestrogenic Anovulation: Normal FSH, LH that may be elevated, normal oestrogen. This is the largest group, accounting for 85 per cent of anovulatory women, and is dominated by polycystic ovary syndrome (PCOS). The ovaries are functional, but ovulation is disrupted by hormonal imbalance elevated androgens, insulin resistance, and an abnormal LH-to-FSH ratio.
WHO Group III Hypergonadotropic Hypo-oestrogenic Anovulation: Elevated FSH, low oestrogen, reflecting ovarian failure. This group includes premature ovarian insufficiency (POI) and diminished ovarian reserve in younger women. The hypothalamus and pituitary are functioning correctly, but the ovaries cannot respond.
The WHO group determines which treatment approach is appropriate. A woman with WHO Group I anovulation needs gonadotrophin supplementation to replace the absent signal. A woman with WHO Group II PCOS needs ovulation induction with medication that overcomes the hormonal disruption. A woman with WHO Group III premature ovarian insufficiency may need donor egg IVF if her own reserve is critically depleted. Nova IVF Kolkata's initial assessment identifies the WHO group before any treatment is initiated.
How Nova IVF Fertility Centre, Kolkata Diagnoses Ovulation Disorders
A precise diagnosis is the foundation of effective ovulation disorder treatment in Kolkata. Treating all ovulation disorders with the same protocol regardless of their cause produces lower success rates and unnecessary medication exposure.
The Diagnostic Workup at Nova IVF Kolkata
The initial assessment at Nova IVF Kolkata for a woman presenting with irregular or absent periods and difficulty conceiving covers:
Hormonal investigation:
-
Day two to three FSH and LH: the FSH to LH ratio and the absolute levels identify the WHO group
-
AMH (Anti-Mullerian Hormone): the most reliable marker of ovarian reserve, detectable at any cycle day
-
Prolactin: hyperprolactinaemia from a pituitary adenoma or medication suppresses hypothalamic GnRH release and causes anovulation excluded in every case
-
TSH: hypothyroidism is a common and reversible cause of ovulatory dysfunction
-
Testosterone, DHEA-S, and 17-OHP: elevated androgens confirm PCOS or, rarely, congenital adrenal hyperplasia
-
Fasting insulin and glucose: insulin resistance is present in 50 to 70 percent of PCOS women and directly drives the anovulatory mechanism
Imaging:
- Transvaginal ultrasound with antral follicle count on day two or three: polycystic ovarian morphology (twelve or more antral follicles per ovary, or ovarian volume above ten mL) is one of the three Rotterdam criteria for PCOS diagnosis
- Pelvic assessment for structural abnormalities including endometriomas and fibroids
The Rotterdam Criteria for PCOS Confirmation:
PCOS is diagnosed when two of the three following criteria are present: oligo or anovulation, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology on ultrasound. A positive diagnosis requires the exclusion of other causes of androgen excess including thyroid disease and congenital adrenal hyperplasia.
Ovulation Disorders Treatment at Nova IVF Fertility Centre, Kolkata: The Complete Pathway
Restoring regular ovulatory function requires an evidence-based, step-up clinical protocol that addresses underlying endocrine imbalances while minimizing complications like ovarian hyperstimulation. Nova IVF Fertility Centre in Kolkata utilizes a personalized treatment continuum advancing systematically from lifestyle and metabolic optimization to oral stimulation, injectable gonadotrophins, and assisted reproductive technologies.
Lifestyle Modification and Weight Management for PCOS
For women with PCOS and elevated BMI, lifestyle modification is the first and most evidence-supported intervention before any medication is introduced. A five to ten percent reduction in body weight in overweight PCOS women produces measurable improvement in hormonal parameters, reduction in LH surge irregularity, and spontaneous resumption of ovulation in a significant proportion of cases.
Nova IVF Kolkata integrates nutritional counselling alongside medical management for PCOS patients, addressing the insulin resistance that drives both the metabolic and reproductive features of the syndrome.
Letrozole: The First-Line Ovulation Induction Agent
The 2023 International Evidence-Based Guideline for the Assessment and Management of PCOS supports letrozole as the preferred first-line agent for ovulation induction in PCOS due to its superior efficacy in achieving ovulation and live births compared to clomiphene citrate. This guideline position reflects the consistent body of evidence showing that letrozole outperforms clomiphene citrate across ovulation rate, pregnancy rate, and live birth rate in the PCOS population.
Letrozole is an aromatase inhibitor that blocks oestrogen synthesis in the early follicular phase. The resulting oestrogen reduction stimulates the pituitary to produce more FSH, driving follicle development while avoiding the anti-oestrogenic endometrial effects of clomiphene. The standard dosing starts at 2.5 mg daily for five days from cycle day three to five, with ultrasound monitoring from day eight to nine to confirm follicle development and time the trigger injection.
A 2025 meta-analysis confirmed that letrozole showed a 12 percent increase in ovulation and a 33 percent increase in pregnancy rates compared to clomiphene citrate in overweight or obese PCOS patients a finding directly relevant to the South Asian PCOS population where obesity and insulin resistance commonly co-exist.
Dr. Anindita Singh at Nova IVF Kolkata presented research on the dual trigger protocol at ISAR 2017, specifically addressing PCOS-related egg maturation optimisation reflecting the centre's specific expertise in managing the nuances of ovulation induction in PCOS beyond standard first-line medication.
Clomiphene Citrate: The Established Alternative
Clomiphene citrate remains a clinically appropriate first-line agent at centres with specific patient populations, cost constraints, and protocol preferences. It acts as a selective oestrogen receptor modulator, blocking hypothalamic oestrogen receptors and stimulating FSH release. Ovulation rates of up to 80 percent are reported in previously anovulatory PCOS women with clomiphene.
Clomiphene resistance failure to ovulate after receiving 150 mg daily across at least three cycles occurs in approximately 15 to 40 percent of women with PCOS. Clomiphene failure ovulation achieved but pregnancy not conceived represents a separate category where the treatment approach requires modification. Nova IVF Kolkata's specialist team identifies resistance and failure patterns early and escalates to second-line treatment without extending unsuccessful cycles.
Metformin: The Insulin Sensitiser in PCOS Management
Metformin addresses the insulin resistance mechanism driving PCOS anovulation rather than directly stimulating ovulation. Used alongside letrozole or clomiphene, metformin reduces androgen production, improves the hormonal environment for follicle development, and in some studies improves ovulation and pregnancy rates above oral agents alone.
A 2025 review confirmed that letrozole plus metformin has a slightly higher ovulation rate compared to letrozole alone in the relevant PCOS subgroup. Nova IVF Kolkata's approach to metformin use in PCOS is individualised based on fasting insulin, glucose, and BMI not applied uniformly to all PCOS patients regardless of whether insulin resistance is present.
Injectable Gonadotrophins: Second-Line Therapy
For women who do not respond to letrozole or clomiphene, or for whom oral agents have failed to produce conception after multiple cycles, injectable FSH or HMG gonadotrophins are the evidence-based second-line treatment for anovulatory infertility. Gonadotrophins directly stimulate the ovary to develop follicles, bypassing the hypothalamic-pituitary axis entirely.
Gonadotrophin protocols for ovulation induction in PCOS require particularly careful dose management because of the risk of OHSS (ovarian hyperstimulation syndrome) the polycystic ovary responds to FSH with more enthusiasm than a normal ovary, and excessive multi-follicular development increases both OHSS risk and multiple pregnancy risk. Nova IVF Kolkata uses low-dose step-up gonadotrophin protocols for PCOS ovulation induction and applies GnRH agonist trigger rather than hCG trigger when excessive follicular response is detected, virtually eliminating severe OHSS risk.
Laparoscopic Ovarian Drilling (LOD)
For women with clomiphene-resistant PCOS who wish to avoid gonadotrophin injections or who have not responded adequately to second-line medical treatment, laparoscopic ovarian drilling is a surgical ovulation induction option. Under laparoscopic guidance, electrosurgical punctures are made in the ovarian surface, reducing the androgen-producing ovarian tissue and restoring a more normal hormonal environment.
LOD produces spontaneous ovulation in approximately 50 to 60 percent of clomiphene-resistant PCOS women and avoids the multiple pregnancy risk associated with gonadotrophin therapy. Nova IVF Kolkata's team coordinates LOD through the associated surgical programme when indicated.
IUI Combined With Ovulation Induction
For couples where ovulation disorder is the primary infertility factor and the fallopian tubes are confirmed patent, IUI (intrauterine insemination) combined with ovulation induction significantly improves conception rates above ovulation induction alone. The prepared sperm sample is placed directly in the uterine cavity at the time of induced ovulation, maximising the probability of fertilisation from a single triggered cycle.
Nova IVF Kolkata offers IUI with monitoring as a distinct treatment option for appropriate candidates couples with unexplained infertility where the primary issue is ovulation timing, mild male factor, or cervical factor. IUI with ovulation induction costs Rs. 8,000 to Rs. 15,000 (USD 96 to USD 180) per cycle at Nova IVF Kolkata.
IVF for Ovulation Disorders: When Simpler Treatments Have Not Worked
For women with ovulation disorders who have not conceived after a genuine course of ovulation induction with timed intercourse or IUI typically three to four cycles with appropriate monitoring IVF represents the most effective next step. IVF with ICSI at Nova IVF Kolkata bypasses the ovulation and fertilisation steps entirely, retrieving eggs after controlled stimulation, fertilising them in the laboratory, and transferring the best-quality embryo into the uterine cavity.
The GnRH antagonist protocol is specifically preferred for IVF in PCOS patients because it allows stimulation to begin without downregulation, and a GnRH agonist trigger can be used instead of hCG to completely eliminate severe OHSS risk in the high-response PCOS ovary. For more on why this protocol matters for PCOS IVF,
The Specialist Team for Ovulation Disorders Treatment at Nova IVF Kolkata
Dr. Anindita Singh (24 years experience, MBBS, DGO, ART Diploma Kiel Germany): Primary clinical focus areas include PCOS and endometriosis. Presented dual trigger protocol research at ISAR 2017 specifically addressing PCOS ovulation induction optimisation. With 2,000+ IVF cycles, Dr. Singh has managed the full spectrum of PCOS presentations from first-line letrozole cycles through complex clomiphene-resistant cases requiring gonadotrophins and IVF.
Read:https://karetrip.com/blogs/female-infertility-treatment-india-women-over-35
Dr. Preeti Mahawar (20+ years, MBBS, DGO, DNB, ART Diploma ISRME): Primary focus on decreased ovarian reserve, including premature ovarian insufficiency the WHO Group III anovulation category where standard ovulation induction is not effective and donor egg IVF becomes necessary. For women with POI driving their ovulation disorder, read: https://karetrip.com/blogs/best-fertility-treatment-low-ovarian-reserve-india
Dr. Aindri Sanyal (Clinical Director, FNB Reproductive Medicine, 4,000+ IVF cycles): Manages complex ovulation disorder cases where multiple prior treatment approaches have failed, including recurrent IVF failure workup for women with PCOS whose prior IVF cycles have not produced live birth despite ovulation.
Dr. Rohit Gutgutia (Medical Director, 19 years): Coordinates combined male and female factor cases where ovulation disorder in the female partner coexists with sperm parameter issues.
Cost of Ovulation Disorders Treatment at Nova IVF Kolkata
Navigating the financial aspects of fertility care is an essential step in planning an effective treatment journey. At Nova IVF Fertility in Kolkata, ovulation disorder management is structured through transparent, stepped-care clinical packages—offering international-standard reproductive medicine at a fraction of Western costs.
| Treatment | Nova IVF Kolkata cost | Equivalent in UK or USA |
|---|---|---|
| Initial consultation and hormonal workup | Rs. 3,000 to Rs. 8,000 (USD 36 to USD 96) | USD 400 to USD 1,500 |
| Letrozole or clomiphene cycle with monitoring | Rs. 5,000 to Rs. 12,000 (USD 60 to USD 145) | USD 500 to USD 2,000 |
| Injectable gonadotrophin cycle with monitoring | Rs. 15,000 to Rs. 30,000 (USD 180 to USD 360) | USD 1,500 to USD 5,000 |
| IUI with ovulation induction | Rs. 8,000 to Rs. 15,000 (USD 96 to USD 180) | USD 1,500 to USD 4,000 |
| IVF with ICSI and antagonist protocol | Rs. 1,00,000 to Rs. 1,50,000 (USD 1,200 to USD 1,800) | USD 12,000 to USD 22,000 |
| Sperm DNA fragmentation test | Rs. 5,000 to Rs. 10,000 (USD 60 to USD 120) | USD 300 to USD 600 |
Nova IVF Kolkata offers flexible EMI payment facilities for couples who need to spread treatment costs across multiple cycles.
The costs presented in this table are indicative estimates based on standard clinical cycles and prevailing currency exchange rates. Final expenses may vary depending on patient age, baseline ovarian reserve (AMH), medication dosages, required stimulation days, additional embryology techniques (such as blastocyst culture or embryo freezing), and individualized diagnostic requirements. A comprehensive, itemized quotation is provided following your clinical evaluation and baseline ultrasound scans.
How Karetrip Connects International Patients to Ovulation Disorders Treatment at Nova IVF Kolkata
Karetrip reviews each patient's hormonal investigation results, menstrual history, and prior treatment records before recommending Nova IVF Kolkata and the most appropriate specialist. For patients from Bangladesh who are making their first fertility consultation, Karetrip coordinates the complete journey from Dhaka medical visa, accommodation in Kolkata, cycle timing around travel, and discharge documentation for obstetric follow-up after a positive result.
Chat with our Medical care assistant, RUA, for quick guidance and support and take the first step toward ovulation disorders treatment at Nova IVF Fertility Centre, Kolkata.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Ovulation disorders require evaluation by a qualified reproductive specialist. Consult a fertility doctor before making any treatment decision.